EMCrit FOAM Feed

EMCrit FOAM Feed

By Scott D. Weingart, MD FCCMScienceMedicineHealth & Fitness
Download on the App Store
  • Favorites

    1,064

    Followers

  • Latest release

    7 days ago

  • Typical duration

    29 min

    per episode

  • If it hooks

    52%

    finish an episode

Based on Podcast App listening data

All EMCrit FOAM Feed episodes

  • EMCrit Wee – Four More Minutes with Rob Mac Sweeney
    So yesterday, I spoke with Rob Mac Sweeney about Intra-Arrest Meds. On that cast, I told you today we would have a bit of discussion on Rob's FOAM. Well here it is...



    Critical Care Reviews
    It's amazing, it's hugely helpful, and it is free. Subscribe ASAP at criticalcarereviews.com.

     

    Critical Care Horizons
    Here is Rob describing this new journal:
    Announcing a new development in critical care publishing.
    It is with great delight we announce the launch of a new open access critical care journal. Critical Care Horizons is a fresh, original voice in the critical care literature, offering thought-provoking, cutting-edge commentary and opinion papers, plus state-of-the-art review articles. As a Journal, we see discussion, commentary, and the sharing of insight, experience and ideas, as central to progress in our speciality. We are free to publish with, free to read, opening authorship opportunity to all working with the critically ill. We are driven by a desire to improve the care we offer our patients, and operate without financial aim or incentive.
    We strive to be different, combining the rapidity, broad exposure, and dynamic discussion characteristic of social media with the academic standards of an indexed, peer-reviewed journal. Covering the full spectrum of clinical care, we welcome submissions from all disciplines involved in the care of the critically ill and injured, from pre-hospital resuscitation to Emergency Department care to ICU-based management to post-discharge follow-up, and anywhere else.
    The Journal publishes dynamically, releasing material to the website as the final PDF as soon as it has cleared peer-review and editorial processes. Issues will be published quarterly, with additional special editions and articles as required. The Journal is run on a not-for-profit basis, with editorial staff operating on a voluntary basis without monetary reimbursement.
    Critical Care Horizons is aligned with the altruistic ethos of the FOAMed movement, and affiliated with several of the leading critical care and emergency medicine blogs. We have an energetic editorial board, consisting of a deliberate mix of clinicians active in social media and world renowned academics. This is a journal for the critical care community, by the critical care community, without access impediment or financial bias. This is your journal. We hope you will enjoy the content, get involved in the discussions available with each article, and, by publishing with us, share your thoughts and opinions with the world.
    With this, we issue a call for both papers and peer reviewers. Neither finance nor profile will be an impedement to publication. The only barrier is you - your willingness to commit time to write and your ability to produce an engaging, skillfully written manuscript. If you have something interesting to say, but feel locked outside the traditional publishing environment, this is your opportunity. If you are an inexperienced author, please enlist the help of an experienced colleague, as formal scientific writing is a skill to be mastered. If you have an idea for a themed issue, and would like to act as a guest editor, please contact the editor-in-chief. Further affilitations from similar altruistic bodies and websites are welcome. The first articles will be published on January 1st 2015.
    Join us on an amazing journey.
     

    Rob Mac Sweeney - Editor-in-Chief

    5 min
  • EMCrit Wee – Rob Mac Sweeney on Intra-Arrest Meds


    Rob Mac Sweeney is an anaesthetist-intensive care doc. His gig is evidence: analysis, assimilation, and dissemination. Tomorrow, you'll hear a ton more about the great stuff he does on sites such as Critical Care Reviews. For today, we discuss the topics raised in my recent posting of my SMACC Intra-Arrest Talk.

     
    17 min
  • Mind of the Resuscitationist – Errors of Commission and Omission


    I received an email from a friend and colleague on how to build mental toughness in our trainees. After hearing the case that spurred the question, I actually began to believe the problem is actually one of self-granted permission to act and the conflict between errors of commission and errors of omission.
    Recommended Reading/Listening

    * Combating omission errors through task analysis and good reminders
    * Rick Body has a great post on the silliness of the interpretation that, "First, do no harm," should inspire passivity
    * Casey Parker could not be restrained by words in the comment section so he recorded his response discussing the 2 modes of a part-time resuscitationist

    Listen to the wee to understand what the frack I am talking about...
    6 min
  • Podcast 124 – The Logistics of Proning for ARDS


    Proning is one of the only evidence-based techniques to affect the mortality of ARDS patients. I've been wanting to do an episode on proning for a while. Serendipitously, Joseph Tonna recently published a piece on the topic in the ACEP Critical Care Section Newsletter. Dr. Tonna is a fellow in Anesthesia Critical Care at the University of Washington. He recently did a rotation on a refractory ARDs unit (read about all of his experiences below) and learned the way they prone. We discuss it on the podcast today.
    ResusReview's Checklist
    Proning Checklist
    Article on the Physiology of Proning
    Eur Resp J 2002;20(4):1017
    Meta-Analysis of RCTs on Proning
    Crit Care Med 2014;42(5):1252
    LITFL's CCC Entry on Proning
    Lots of good stuff here
    Video on Proning from the Guerin Study

    Here is the Dr. Tonna's Original Piece:
    Prone Positioning: An experience of actually doing it
    by Joseph E. Tonna, MD, Associate Newsletter Editor. This piece was originally published in the ACEP Critical Care Section Newsletter

     

    Most intensivists have read Guérin’s 2013 NEJM study on the mortality benefit of prone positioning. Previous studies [1,2] have established that dorsal consolidations improve when the patient is placed prone. Taken together, the practice of prone positioning in select patients makes sense. Despite this, I haven’t found that it is done as often as one might infer from the robustness of its benefit in this study or others. In my experience, while we are likely to notice the profound dorsal pulmonary consolidations on our patient’s CT scans, we don’t take the next step and actually prone the patient until we have already progressed further down the path towards worsening hypoxemia—often only when the pO2/FiO2 ratio is well below 150 on upwards of 70% FiO2. At this stage, we begin to consider the patient “refractory” and allow ourselves to begin the intellectual path of discussing the evidence for and risk/benefit or cost/benefit of therapies like inhaled nitric oxide (iNO), epoprostenol, prone positioning, high frequency ventilation, paralysis or extracorporeal membrane oxygenation (ECMO). The evidence for many of these therapies is thin at best, and given how infrequently we reach these states of worsening refractory hypoxemia, and gain personal experience with implementing them, many newly trained intensivists will finish training having managed no more than a handful of patients on these therapies. As we all know, increased volume leads to increased comfort and competence; so as part of my fellowship training, I wanted to know what it looked like to routinely implement these therapies. Did they work? What did this process actually look like?

    Prior to turning a patient prone, the medical team places pillows on the chest, the thighs, and the feet. Sheets are used to wrap the patient in preparation for proning.

    I had the opportunity recently to train at Legacy Emanuel Medical Center in Portland, OR at the Randall & Emanuel Severe Cardiopulmonary Failure and ECMO (RESCUE) Center under two talented surgical intensivists, Drs. Andrew Michaels and Sandra Wanek. Patients brought to this unit have already failed conventional therapies for hypoxemic respiratory failure, and often already have a P/F of <100 on 80-100% FiO2. These patients have not only failed excellent critical care,
    24 min
  • EMCrit Wee – Sean Townsend of the SSC and the ProCESS Trial


    Recently, I got to talk to Sean Townsend, MD; a critical care doc and a member of the Surviving Sepsis Campaign (SSC) steering committee. The spark for this conversation was the recent SSC response to the ProCESS trial (read below) as well as the elimination of CVP and ScvO2 from the National Quality Forum (NQF) sepsis bundle.

    * Harmonization Paper that Dr. Townsend Mentioned (Intensive Care Med. 2013 Oct;39(10):1760-75.)
    * Definitely read this editorial on legislating sepsis care
    * Here is the SSC response to ProCESS:

    Surviving Sepsis Campaign Responds to ProCESS Trial
    The Surviving Sepsis Campaign (SSC) has received many inquiries regarding the recent publication of the Protocol-Based Care for Early Septic Shock (ProCESS) trial’s effect on the continuing activities of the Campaign.

    * The ProCESS trial reflects the consensus that early diagnosis of septic shock is essential. Notably, all groups in the study received on average more than 2 liters of fluid prior to randomization and more than 75% received antibiotics prior to randomization--both elements of the 3-hour Surviving Sepsis Campaign bundle. (2) The editorial accompanying the ProCESS study highlights these points. (3)
    * The 18% mortality rate in the “usual care” arm of ProCESS illustrates a dramatic change in the management and outcomes of patients with septic shock. (1) In comparison, septic shock mortality was 46.5% in the 2001 early goal-directed therapy trial by Rivers. (4) Given that 70% of the hospitals in ProCESS had some form of “sepsis protocol,” we believe this mortality rate demonstrates the success of the SSC in increasing awareness and attention to the challenge of early identification and management of these vulnerable patients.
    * Given the remarkably low mortality rate in the control arm of ProCESS, the existence of sepsis protocols in the majority of participating study institutions, and the pending results of 2 large ongoing trials (the Australian Resuscitation In Sepsis Evaluation Randomised Controlled Trial [ARISE] and The Protocolised Management in Sepsis Trial [ProMISe]), the SSC has no plans to revise the bundles or National Quality Forum (NQF)-endorsed measures at this time.
    * ProCESS does not address the protocolized management of patients with severe sepsis without septic shock, a group of patients for whom early detection and treatment remain critical. The aggressive protocolized management of these patients who do not yet have shock has likely lowered severe sepsis and septic shock mortality since the inception of the SSC. The recently formed Society of Critical Care Medicine/Society of Hospital Medicine (SCCM/SHM) Early Diagnosis and Treatment of Severe Sepsis on the Hospital Floors Collaboratives will focus in large part on this population. Further, the ProCESS results have no impact on the 3-hour bundle, which is the primary focus for the Collaboratives.
    * Regarding the SSC 6-hour bundle:



    * A companion paper appears to support a mean arterial pressure (MAP) target of 65 mm Hg, which is one of the indicators in this bundle. (5)
    * The ProCESS paper does not address repeating lactate measures in patients with elevated lactate while literature supports doing so. (6,7)
    * The majority of the patients in the usual care (56.5%) and protocol-based standard care arms (57.9%) of ProCESS had central lines inserted as part of clinical care. (1) The 6-hour bundle asks only that central venous pressure (CVP) be measured and that a venous blood gas be sent fr...
    18 min
  • Podcast 123 – Selective Aortic Arch Perfusion (SAAP) with Jim Manning
    A few weeks ago, we discussed REBOA, a cutting edge procedure to control hemorrhage. Let's go beyond cutting edge to the future of trauma and medical arrest care using a similar aortic catheter. This one allows you to administer blood and drugs to the proximal aorta.

    Jim Manning, MD has been working on these issues for over two decades in his lab in North Carolina. This may very well be the future of CPR for medical and traumatic arrests.

    Here are Dr. Manning's Disclosures: Inventor on patents for the Selective Aortic Arch Perfusion technology that are assigned to the University of North Carolina at Chapel Hill; Co-Founder of Resusitech, Inc., a medical device company developing invasive resuscitation technologies.
    Selective Aortic Arch Perfusion
     

    SAAP Catheter Prototype

    The following slide shows where SAAP may fit in with the other therapies for cardiac arrest:



    And this one shows a possible progression during arrest:


    Update: Want More?
    Jim gave a lecture for GSA HEMS that is fantastic!
    What do you think? Comment Below.
    Now on to the Podcast...
    29 min
  • EMCrit Wee – A Cric Case with Rob Bryant

    The Case:
    Rob got permission to share:

    INITIAL PRESENTATION:

    30 year old male with past history of SCC of the tongue at age 14 who presented with cough, and dyspnea with concerns for recurrent pneumonia. He was still on antibiotics and steroids after a recent hospitalization for pneumonia.

    His cancer recovery was hampered by osteo-radio-necrosis of his jaw, and he was left with a scarred larynx, baseline trismus with incisor to incisor distance of <2cm, and some thickening of the anterior neck tissues. He had a G-tube for feeding.

    He had normal room air sats, no stridor, productive cough and no fever. Chest Xray was normal, and he was considered safe to go home and follow up with his pulmonologist the next day. The family was nervous about going home so he was observed overnight in the ED.

    A very specific discussion was has with the patient regarding the challenges emergent management of his airway would represent:

    “I love to manage airways, but your airway scares me, and I would never want to be the one to intubate you”

    “If you have an airway emergency on the floor, it would take longer for someone to cric you than if you had an airway emergency at home, and had to present via ems and have a surgical airway performed in the ED”

    He was discharged from the ED the next morning with some racemic Epi to try at home.

     

    RE-PRESENTATION:

    He represented 4 days later in respiratory distress with 36 hours of ‘anxiety’ symptoms that had not been helped by escalating doses of benzodiazepines.

    No fever, no cough, very hoarse voice at home.

     

    HR 140, BP 160/110, RR 29. Sats 86% RA, 98% 15L NRB

    ETCO2 84.

     

    Altered, sweaty, moving minimal air, and non verbal with significant stridor.

    Initial interventions:

    Racemic epi nebs,

    125mg solumedrol iv

    Glycopyrollate 0.2 mg iv.

    Lido 4% neb.

     

    VBG: pH 7.17, pCO2 104.

     

    Anesthesia was called for Awake FiberOptic Intubation (AFOI) if a trial of BiPAP failed. Due to concerns that NIV could worsen his laryngeal irritation, or that giving Ketamine to help him tolerate the BiPAP could cause laryngospasm (est 1:200 risk) BiPAP was not started until anesthesia was present and ready to perform AFOI.

     

    Anesthesia presented promptly and agreed with AFOI plan after BiPAP.

    Beside table was set up with 4x4’s with betadine, trach (6.0mm), pocket bougie, and #10 blade scalpel, and gloves. Lido 1% w epi was prepared.

    Pt kept at 20 degrees HOB elevation, NC at 15L, then BiPAP at 15/5 was started with no decrease in his work of breathing.

     

    3 AFOI attempts were made, with each attempt aborted once sats hit 90%, the patient was hard to bag due to laryngeal stenosis, but with assisted spontaneous ventilations additional attempts were considered appropriate.

    The neck was palpated, and prepped prior to first AFOI, and injected w lido w epi after 2nd AFOI.

    3rd AFOI was with glidescope assist. Glidescope could barely fit into the mouth, and there were no obviously recongnizable laryngeal structures.

    During 3rd AFOI cricothyroid membrane was punctured with 27g needle on the Lidocaine with epi syringe and air was aspirated to confirm location.

    The patient received 1mg per kg Ketamine iv prior to incision for cricothyrotomy.

    With sats of 92%, a midline 3cm incision made, then horizontal incision 1.
    13 min
  • Podcast 122 – Cardiac Arrest after the Toxicology of Smoke Inhalation with Lewis Nelson


    We had a case a few months ago at Janus General--very sad and very scary. The patient came in after a house fire. He had some burns, but not enough to be the cause of his arrest. Instead, it had to be the asphyxia and possible toxicology of the smoke inhalation. I wanted to get a better idea of ideal care for these patients; for that I needed a toxicologist.

    Few tox folks are smarter than Lewis Nelson, MD of the NYC Poison Center.

    Note: In this episode we don't deal with the thermal injury of smoke inhalation
    Cyanide Toxicity

    * Empiric administration of  Hydroxocobalamin 5 g rapid IV drip x 1
    * Even better if this can be given at the scene as soon as the patient arrests or is profoundly hypotensive
    * Messes with labs that use colorimetric probes (cooximetry, lactate, LFTs, etc.) Get blood for cooximetry before giving the med if at all possible
    * Dr. Nelson doesn't recommend giving sodium thiosulfate in addition to the Hydroxocobalamin
    * An IM version is in the pipeline--this will be easier for EMS/emergency use

    Hydroxocobalamin

    You'll need 200 ml of Saline
    Carbon Monoxide

    * Put the patient on 100% fiO2
    * Not much to do beyond that until the patient stabilizes
    * See LITFL for more on CO

    Methemoglobinemia

    * Caused by Hb oxidation from the heat of the fire
    * Administer Methylene Blue 2 mg/kg x 1 IVP
    * May be worthwhile to start a drip if patient has resistant hypotension, but this is an unproven therapy

    Now on to the Podcast...
    19 min